Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.
Maier LA, Barkes BQ, Mroz M, Rossman MD, Barnard J, Gillespie M, Martin A, Mack DG, Silveira L, Sawyer RT, Newman LS, Fontenot AP.
Maier LA, et al. Among authors: sawyer rt.
Respir Med. 2012 Dec;106(12):1810-3. doi: 10.1016/j.rmed.2012.08.014. Epub 2012 Sep 11.
Respir Med. 2012.
PMID: 22974830
Free PMC article.
Clinical Trial.
No abstract available.